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Abstract
Introduction
The detection of atherosclerotic plaques at risk for disruption will be greatly enhanced by
molecular probes that target vessel wall biomarkers. Here, we test if fluorescently-labeled
Activatable Cell Penetrating Peptides (ACPPs) could differentiate stable plaques from vul-
nerable plaques that disrupt, forming a luminal thrombus. Additionally, we test the efficacy
of a combined ACPP and MRI technique for identifying plaques at high risk of rupture.
Methods and Results
In an atherothrombotic rabbit model, disrupted plaques were identified with in vivoMRI and
co-registered in the same rabbit aorta with the in vivo uptake of ACPPs, cleaved by matrix
metalloproteinases (MMPs) or thrombin. ACPP uptake, mapped ex vivo in whole aortas,
was higher in disrupted compared to non-disrupted plaques. Specifically, disrupted plaques
demonstrated a 4.5~5.0 fold increase in fluorescence enhancement, while non-disrupted
plaques showed only a 2.2~2.5 fold signal increase. Receiver operating characteristic
(ROC) analysis indicates that both ACPPs (MMP and thrombin) show high specificity
(84.2% and 83.2%) and sensitivity (80.0% and 85.7%) in detecting disrupted plaques. The
detection power of ACPPs was improved when combined with the MRI derived measure,
outward remodeling ratio.
Conclusions
Our targeted fluorescence ACPP probes distinguished disrupted plaques from stable pla-
ques with high sensitivity and specificity. The combination of anatomic, MRI-derived
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predictors for disruption and ACPP uptake can further improve the power for identification of
high-risk plaques and suggests future development of ACPPs with molecular MRI as a
readout.
Introduction
Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity in devel-
oped countries [1]. Atherosclerosis is a major contributor for CVD, and its complex pathology
encompasses many features, including retention of lipids, infiltration of macrophages, deposi-
tion and degradation of the extracellular matrix proteins (MMP), increased inflammation and
enzymatic activity in the arterial wall [2,3]. Although atherosclerotic plaques develop a range
of pathophysiological features, a simple functional classification would be to label a plaque as
either “stable” or “high-risk/vulnerable”. Stable plaques can remain clinically silent for decades;
however, vulnerable plaques may suddenly disrupt to form a luminal thrombus and lead to
clinical manifestations, including myocardial infarction and stroke. The ability to determine
whether or not a specific plaque is likely to disrupt will guide clinical treatment and decrease
unnecessary, expensive, and sometimes highly invasive, treatment of stable plaques that would
not cause a future cardiac event.
Recently, strategies employing targeted molecular probes in conjunction with various imag-
ing techniques have been able to visualize specific biological processes in atherosclerosis,
including extracellular matrix changes [4], macrophage infiltration [5], neovascularization [6]
and enzymatic activity [7–9], all of which provide important information on plaque stability.
Among these imaging modalities, MRI has been used, alone, to identify numerous plaque fea-
tures, including plaque composition [10–12], vascular remodeling [13,14], endothelial shear
stress [15] and neovascularization [16]. The potential of MRI for monitoring atherosclerosis
could be enhanced by rationally designed molecular probes that are targeted to biomarkers
known to be associated with plaque vulnerability.
Among the targets that were deemed to be highly active and physiologically relevant, MMPs
and thrombin are of particular interest. MMPs and thrombin have been linked to both athero-
genesis and plaque vulnerability [17]. MMPs are a family of proteases that degrade the extracel-
lular matrix (ECM), which can destabilize the fibrous cap [18]. Higher MMP levels have been
detected in regions of low endothelial shear stress, a characteristic of plaque progression and
vulnerability, in animal models [15,19]. Increased MMP activity has also been detected in
human plaques both in vivo and ex vivo [20,21]. MMP levels have been shown to indirectly
influence thrombin activity via platelet aggregation [18]. The enhanced thrombin activity is
important in the initiation, progression, and destabilization of plaques [22]. Thrombin is a
trypsin-like serine protease with an inactive precursor, prothrombin, and is well established as
a key regulator of blood coagulation. Prothrombin is activated by factors released from epithe-
lial cells and macrophages in atherosclerotic plaques [23]. This can cause plaque instability by
inducing intraplaque hemorrhage or by increasing the local ECM degradation by activating
MMPs [18,24,25]. Therefore, probes that target MMPs or thrombin may help better the under-
standing of atherosclerotic progression and provide a new tool for diagnosing and monitoring.
In this study, fluorescent-labeled Activatable Cell Penetrating Peptides (ACPPs), which
were designed to target MMPs or thrombin, were tested in an animal model of atherothrombo-
sis. ACPPs constitute a polycationic cell penetrating peptide (CPP) domain, a neutralizing
polyanion and a cleavable linker to form a hairpin structure. The linker region was specifically
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designed so that protease dependent cleavage creates probe activation, releases CPP which
allows the fluorescent-labeled CPP adherence in localized regions of elevated protease activity,
thus providing a tool to generate an in situ spatial and focal protease activity map in diseased
tissues [7,26]. We previously demonstrated the correlation of MMP and thrombin activated
ACPPs uptake with plaque load and plaque severity in a murine model. However, the murine
atherosclerosis does not mimic the stages of human plaques, and luminal thrombosis does not
occur [7]. Furthermore, the challenge that must be met for future clinical applications is not
simply detection of enzyme activity, which is present in all stages of atherogenesis [27], but the
discrimination of individual high-risk plaques from stable plaques in vessels that often contain
multiple plaques at various stages of risk.
The present study makes use of an established preclinical animal model (rabbit) of athero-
thrombosis that encompasses the above advantages for potential future translation to human
disease and which simplifies the complicated plaque classification methods into a binominal
model [14,15]. The novelty of this study is the combination of quantitative in vivoMRI of pla-
ques and subsequent post-mortem fluorescence imaging of ACPPs to correlate disease state
with localized protease activity in individual plaque. We hypothesized that these probes would
show enhanced localized probe uptake in arterial plaques that are at high-risk for disruption,
and the contribution of MRI-derived predictors would further complement the ACPPs in
detecting disrupted plaques.
Material and Methods
Peptide synthesis and fluorophore labeling
Peptides were synthesized in house using standard protocols for Fmoc solid-phase synthesis
and all peptides were amidated at their C-termini [26,28]. Peptides were N-terminally capped
with either an acetyl or succinyl group on solid phase. Peptides were then labeled with Cy5
through a D-cysteine residue using Cy5-maleimide and standard coupling conditions. Specific
peptide compositions were: thrombin cleavable peptide (DPRSFL–ACPP), Succinyl-(D-gluta-
myl)8-(5-amino-3-oxapentanoyl)-DPRSFL-(D-argininyl)9-Cy5-D-cysteinamide; MMP cleav-
able peptide (PLGLAG–ACPP),Acetyl-(D-glutamyl)9-(5-amino-3-oxapentanoyl)-PLGLAG-
(D-argininyl)9-Cy5-D-cysteinamide; and control peptide (PEG-ACPP), Acetyl-(D- glutamyl)
9-[NH(CH2CH2O)2CH2CO]2-(D-argininyl)9-Cy5-D-cysteinamide. All peptides were puri-
fied to greater than 95% purity using C–18 reverse phase HPLC with a 20–50% acetonitrile gra-
dient in 0.1% TFA and the mass was confirmed by mass spectrometry [29].
Animal model and timeline
Male New Zealand white (NZW) rabbits (N = 25) entered the study at 3 months old. Among
which, 21 rabbits went through a 12-week atherogenic protocol, including 8 week high choles-
terol diet (HCD, 1%), balloon surgery (incision side: right femoral artery), as previously
described [14,30]. The remaining 4 rabbits (age, weight matched) were untreated, non-athero-
sclerotic control rabbits. After the 12-week diet treatment, thrombosis was induced via two
pharmacological triggering sessions (Russell viper venom, 0.15 mg/kg IP; histamine, 0.02 mg/
kg IV), which took a span of 48 hours in total. MRI of rabbit’s abdominal aorta was acquired
both pre- and post- the triggering events [14,15]. After MRI, these rabbits were further divided
into 5 experimental groups randomly (Table 1). Groups A (n = 9), B (n = 8) and C (n = 4) were
atherosclerotic rabbits injected (IV) with 300 nmoles MMP-ACPP, thrombin-ACPP or
PEG-ACPP respectively. Groups D-E (n = 2), included non-atherosclerotic rabbits, and was
injected with the MMP-ACPP or thrombin-ACPP respectively. Because of the low tissue pene-
tration depth of fluorescence signals, it was necessary to acquire images ex vivo. For contrast
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optimization purpose, probe was allowed to circulate for 6hrs. Animals were then sacrificed by
pentobarbital (>120mg/Kg, IV) and aortas was excised and extended to physiological length
and pinned down on a fluorescence free sample tray for optical imaging. Finally, transverse
cryosections (10 μm) of aortas were collected and stained with Masson trichrome (Sigma
Aldrich) to identify cellular components and thrombi. Meanwhile, at the end of the 6-hour
ACPP circulation period, tissues from thoracic aorta, liver and muscle, were harvested, homog-
enized. The fluorescence readings of Cy5 were taken with 630nm (excitation) and 680nm
(emission) for homogenized suspensions. The details and the relevant result were shown in the
supporting data (S1 Appendix). The timeline of the study is summarized in Fig 1. This study
was approved by the Institutional Animal Care and Use Committee (IACUC) of Boston Uni-
versity (protocol number: AN14245).
Imaging and histology alignment
Prior to actual MRI data acquisition, an ungated coronal 3D phase contrast MR angiogram
was acquired as a scout image using a T1-weighted, fast-filed echo sequence. The left renal and
iliac bifurcations on the scout image served as anatomic markers to plan the following MRI
acquisition, and match with fluorescence imaging and histology (S2 Appendix).
MRI data acquisition and analysis
In vivoMRI was using a 3 Tesla (3T) Intera Philips System (Cleveland, OH). Rabbits were
sedated by acepromazine (0.75 mg/kg; IM), ketamine (35 mg/kg; IM) and xylazine (2.5 mg/kg;
IM), and then placed in a 6-element knee coil in the supine position. The heart and respiration
rate were carefully monitored during the whole MRI session. The pre- and post- trigger MRIs
were performed using the same acquisition protocols. The ECG gated T1 black blood (T1BB)
images with fat suppression were acquired in the transverse plane starting from the left renal
bifurcation to the iliac bifurcation using the following parameters: slice thickness = 3mm,
gap = 1mm, FOV = 120 x 125mm2, acquired matrix = 384x362, reconstructed
resolution = 234μm2, TR = 2 cardiac cycles, TE = 10ms, acceleration factor = 15, flip
angle = 90°, IR delay = 350ms, number of averages = 2, sense factor = 2, and a total scan time
of about 7~8min. Then gadolinium chelate (Gd-DTPA, 0.1mmol/kg, Magnevist, Germany)
was administrated intravenously before un-gated phase contrast MR angiography (PC-MRA)
acquisition. The parameters for PC-MRA were: slice thickness = 2mm, gap = 1mm,
FOV = 120x125mm2, TE = 7.4 ms, TR = 17ms, flip angle = 15°, number of averages = 2,
Matrix = 128x122, acquired resolution = 977x984 μm2, reconstructed
resolution = 190x190 μm2. Finally, post contrast-enhanced (CE) T1BB images were acquired
10~15 min after Gd-DTPA injection with parameters identical to the previously described
T1BB imaging.
The pre-triggering MRI analysis was performed in ImageJ (NIH). The contours for the ves-
sel area (VA) were manually traced slice-by-slice using the PC-MRA images. After correction
Table 1. Experimental groups.
Experimental Group Diet Balloon surgery Fluorescence probe Number of rabbits
A 1% cholesterol Y MMP-ACPP 9
B 1% cholesterol Y Thrombin-ACPP 8
C 1% cholesterol Y PEG-ACPP 4
D Normal N MMP-ACPP 2
E Normal N Thrombin-ACPP 2
doi:10.1371/journal.pone.0139833.t001
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for vessel tapering, the image slice with the least plaque area was chosen as a reference slice and
the remodeling ratio (RR) was calculated [14] by VAlesion/VAreference. To quantify gadolinium
uptake, the average intensity of the vessel wall of each slice was measured from the CE T1BB,
and normalized to intensity measurement of the matched non-contrast enhanced T1BB
images, which generates a Gd enhancement ratio (GdR). Post-trigger T1BB images were to
help to register disrupted plaques, based on the presence or absence of mural thrombus, to fol-
lowing ex vivo fluorescence experiment.
Fluorescence imaging and data analysis
The ex vivo aortas were first imaged in closed-view using an IVIS Spectrum imaging station
(Caliper, Hopkinton, MA). 640nm excitation was used. The emission filter was tuned to
680nm and the exposure times were set between 0.25-2s. All comparisons within each figure
are presented with the same exposure time. To match MRI slices, the fluorescence images of
the closed-view aorta were segmented into continuous 4mm axial segments. Each segment was
Fig 1. Timeline of the experiments. The animal preparation period took 12 weeks in total. Rabbits were fed on high cholesterol (1%) diet for continuous 8
weeks, followed by a 4-week normal diet treatment. The balloon surgery was given to rabbits two weeks into the high cholesterol diet to introduce endothelial
denudation. After the animal preparation, pre- and post-trigger MRI scans were performed 48 hours apart prior and after two pharmacological triggerings. The
ACPP probe was injected into rabbits intravenously after the 2nd MRI section and allowed to circulate for 6 hours. The animals then were sacrificed and the
fluorescent imaging was performed on extracted aortas.
doi:10.1371/journal.pone.0139833.g001
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assigned as disrupted or non-disrupted based on visual inspection described later. The average
fluorescence signal for each segment was obtained and normalized to signal from left femoral
artery (without endothelial denudation/visually presented atherosclerosis) to obtain the fluo-
rescence enhancement ratio (FER). To further clarify the major source of fluorescence signal at
disrupted regions, aortas were opened longitudinally and then imaged (open-view) again with
both thrombi attached and removed from the underlying plaque. During each optical image
session, a reflective (photographic) image was acquired using the same geometric setting for
alignment purpose. Regions of interest (ROIs) of the detached thrombi and surrounding pla-
ques were manually traced, and signals within ROIs was averaged and normalized.
Statistical analysis
Data are presented as mean ± SD. Comparisons between groups were performed using the
unpaired student t-test. A two-tailed probability value of p< 0.05 was defined as statistically
significant. The Receiver Operating Characteristic (ROC) curve was to assess the power of
FER, RR and GdR in distinguishing disrupted vs. non-disrupted regions. The test accuracy was
measured by the area under curve (AUC). An AUC<0.50 was defined as a test failure, and the
larger the AUC the stronger the parameter’s detection power against plaque disruption. The
integrated power of combining the above parameters in distinguishing plaque rupture was also
evaluated. The GdR, RR and FER were first normalized to the scale of 0~10. The weighted asso-
ciation value was obtained using the equation: Si predictoriweighti. Where, predictori represents
the normalized value of either GdR, RR or FER, and weighti represents and percentage of con-
tribution from the corresponding predictor with a range of 0~100% and an interval of 5%. The
ROC analysis was performed for each combination of different weights. The weight combina-
tion with the largest AUC is considered as the optimized combined predictor.
Disrupted plaque characterization
The presence or absence of attached thrombus could be identified and documented by white-
light visual inspection when opening the aorta (Fig 2). Segments with a mural thrombus
attached were defined as disrupted, and the ones without as stable. This was used as the gold
standard to distinguish disrupted and non-disrupted plaques.
Results
Atherosclerotic plaques were observed in all experimental rabbits on the high cholesterol diet
(Groups: A-C). Nine atherosclerotic rabbits were studied with the MMP-ACPP, and 8 with the
thrombin-ACPP probe; a total of 47 segments encompassing disrupted regions and 239 seg-
ments in non-disrupted regions were analyzed quantitatively.
Fluorescence images
Representative fluorescence images (closed-view) of rabbit aortas are shown in Fig 3a–3e.
MMP or thrombin targeted ACPPs (Fig 3a and 3b) experienced substantial increased uptake in
atherosclerotic regions, as compared to the three control groups: two groups of non-atheroscle-
rotic rabbits injected with either targeted ACPPs (Fig 3d and 3e), and one group with athero-
sclerotic rabbits with control uncleavable PEG-ACPP (Fig 3c). To explore whether the targeted
probes would accumulate excessively in regions at high-risk region, the plaques were further
divided into disrupted and non-disrupted groups. At disrupted region, the targeted ACPPs
(Fig 3f) showed significant (all p<0.001) signal increase (MMP/thrombin probe: 4.5±1.0/5.0
Molecular Imaging of Disrupted Vulnerable Plaques
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±1.1) as compared to non-disrupted areas (MMP/thrombin probe: 2.2±1.0/2.5±1.1); in con-
trast, similar signal enhancement was not observed for the control PEG probe.
To examine whether the high fluorescence signal at the sites of plaque thrombosis origi-
nated from the plaque or the thrombus, the aortas were opened longitudinally and the thrombi
removed from their attachment sites. As illustrated for the MMP-probe in Fig 4a, the greatest
enhancement originated from the underlying plaque rather than from the attached thrombus.
This was confirmed by statistical analysis of data for both probes in all rabbits (Fig 4b and 4c).
In the longitudinally opened images, the underlying plaques showed a 4.0±1.1 signal increase
for the MMP probe and an even higher increase (6.8±2.0) for the thrombin probe.
Correspondence between fluorescence and MRI
To explore whether or not MRI derived predicators are complementary to ACPP measure-
ments in disrupted regions, the uptake of gadolinium chelate and outward remodeling from in
vivoMRI images and corresponding ex-vivo measured fluorescent signal were analyzed
together. Fig 5 shows examples of MRI images representative of non-disrupted (Fig 5a and 5b,
bottom row) and disrupted (Fig 5a and 5b, upper row) plaques co-registered with the corre-
sponding fluorescence and histological images of the vessels. Both disrupted regions were
accompanied by higher Gd-DTPA uptake than the non-disrupted plaques in the pre-trigger
image. However, only one of the presented disrupted regions showed excessive outward
remodeling (Fig 5a). The discrepancy between ACPP and MRI- derived measures suggest that
the uptake of ACPPs may represent a different biological process as compared to remodeling
Fig 2. Identification of thrombus. The aorta was cut open longitudinally to reveal the internal structure. One
dark region (green bracket) on the reflected image (a) represents an attached thrombus. However, the dark
region in the reflected images is a not reliable criterion as white-light visual inspection, since dark regions may
also indicate clotted blood and or normal vascular wall without presence of fatty streaks. The gold standard to
verify the presence of a thrombus is visualization by naked eye in the excised aorta, shown as the example
light-microscopy photo (b).
doi:10.1371/journal.pone.0139833.g002
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and Gd-DTPA uptake. Thus the ACPPs and the MRI measures might complement each other,
and the combination of the two might provide more predictive power than each method alone.
To address this issue, Receiver Operating Characteristic (ROC) analysis was performed for the
following factors, including FER, GdR and RR, both alone and combined.
When comparing each single factor, the targeted ACPPs demonstrated superior detection
power. The AUC was 0.79±0.05 for the MMP probe and even higher (0.90±0.05) for the
thrombin probe. The optimal cutoff threshold was 3.5/4.0 fold (MMP / thrombin), with corre-
sponding specificities of 84.2%/ 83.2% (MMP / thrombin) and sensitivities of 80.0%/ 85.7%
(MMP / thrombin). The remodeling ratio showed a smaller AUC (0.69±0.05) and the GdR
showed an even smaller AUC (0.51±0.05, Fig 6). The detection power for plaque disruption
was further increased when both MRI remodeling ratio and ACPP uptake was considered
together. For the MMP-ACPP, the maximum AUC (0.81±0.05) was achieved when the
Fig 3. Representative ex-vivo fluorescence images of rabbits in 5 experimental groups. group A, HCD
+MMP-ACPP(a); group B, HCD + Thrombin-ACPP (b); group C, HCD + PEG-ACPP(c); group D, normal diet
+ MMP-ACPP(d); normal diet + Thrombin-ACPP(e). Note that only one probe is injected into an animal, and
all figures are from different animals. Within each experimental group, the closed view fluorescent images are
presented with overlaid reflected images. The locations of thrombi are indicated by green brackets. Two-
tailed t-test showed that fluorescence of ACPP probes was significantly higher in disrupted regions (DP)
(p<0.001) compared to non-disrupted plaque regions (NP), whereas the non-cleavable PEG-ACPP had
similar uptake into both regions (f).
doi:10.1371/journal.pone.0139833.g003
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combined predictor had contributions comprised of 60% ACPP uptake and 40% remodeling
ratio. Similarly, for the thrombin probe the maximum AUC (0.92±0.05) was achieved when
the combined predictor contributed by 80% ACPP uptake and 20% remodeling ratio. Including
the GdR in the model did not generate better predictions. The results for different predictors
were summarized in Table 2.
Discussion
In this study, we show that two novel, targeted fluorescent ACPPs detected disrupted plaques
with high sensitivity and specificity in a rabbit model of accelerated atherosclerosis. As with any
animal model, the rabbit model used here cannot completely mimic atherosclerotic disease pro-
gression found in humans. However, this rabbit model develops 6 of the 8 AHA categories for
human plaques, and the disrupted plaques shared several histological features known to be associ-
ated with vulnerable plaques in humans [30,31]. Our model uses the pro-coagulant factor (viper
venom) and a vasoconstriction agent (histamine) as plaque rupture catalysts. Although the exact
mechanism for plaque rupture in humans has not been identified, platelet activation and
Fig 4. Comparison of fluorescence signals from thrombi and the surrounding atherosclerotic plaque
in the experimental group.HCD +MMP-ACPP (a,b) and HCD + Thrombin-ACPP(c). The images from left
to right in a are: closed view fluorescence image, opened and zoomed-in fluorescence/reflected images with
the thrombus (green arrows) attached at its original site, opened and zoomed-in fluorescence/reflected
images with the thrombus removed. The dark signal of the aorta on the reflected image comes from clotted
blood and relatively healthy vessel wall (without obvious fatty streaks). Plaques appeared as brighter (gray-
ish) signal. The bar graphs (b,c) give the statistical analysis of fluorescence signal for the underlying
disrupted plaques (DP) and the overlaying thrombi (p<0.001).
doi:10.1371/journal.pone.0139833.g004
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adhesion and the release of vasoconstriction molecules are possible critical steps in the process
[32]. The induced thrombus is platelet rich with fibrin and collagen [33], and has been shown to
replicate features of human thrombosis including tissue factor expression and its regulation by
NF-kB [34,35]. This rabbit model provides a method for studying thrombosis in a time-con-
trolled manner and enables objective testing of protease cleavable probes for identifying high-risk
plaques by providing a simplified, yet effective binominal plaque classification (disrupted vs. non-
disrupted), rather than broad and complicated histological features of vulnerability.
Fig 5. Representative fluorescence images and co-registered MRI images for rabbits from group A: HCD +MMP-ACPP(a) and group B: HCD
+ Thrombin-ACPP(b). The closed view of the fluorescence images shows a sub-section of abdominal aorta and the corresponding open view reflected
images showing the location of thrombi (green brackets). The regions within the two black lines represent examples of non-disrupted and disrupted plaques
respectively, and correspond to the MRI images on the right. All MRI images were obtained after gadolinium-DTPA injection according to our acquisition
protocols; illustrated are the pre-triggering MRA and the fat-suppressed T1BB images obtained before and after pharmacological triggering (from left to right).
Thrombi are marked by green arrows in post-triggering Gd-T1BB (T1 black blood) images. With the current resolution of MRI, it is very difficult to distinguish
different layers of plaque. Hence, in the post-triggering MRI, the formed thrombus, which is on a relatively macro-scale, instead of plaque details, was
observed. The corresponding histological images (after the thrombus was removed) with trichrome staining were presented on the very right column.
doi:10.1371/journal.pone.0139833.g005
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Currently, various imaging methods have made advances in detecting “high-risk” plaques
among stable ones in human vascular disease. In addition to traditional technology, such as
computed tomography (CT) or ultrasound, which focuses on occlusion of lumen, emerging
methods have started to concentrate on functional aspects of atherosclerosis. For example,
Fig 6. ROC analyses. The Gd-DTPA uptake did not show a strong prediction for plaque rupture, with AUC = 0.51±0.05 (a). The remodeling-ratio (RR)
showed an AUC of 0.69±0.05 (b). Its optimal cutoff was 1.06, with a corresponding specificity of 84.2% and sensitivity of 58.5%. The area under the curve
(AUC) was 0.79±0.05 for the MMP-ACPP (c) and 0.90±0.05 for the Thrombin-ACPP probe (d). The optimal cutoff threshold was 3.5/4.0 fold (MMP-ACPP/
Thrombin-ACPP), with corresponding specificities of 84.2%/ 83.2% and sensitivities of 80.0%/ 85.7%. The detection power for plaque disruption was further
increased when both MRI remodeling ratio and ACPP uptake was considered together. For the MMP-ACPP, the maximum AUC (0.81±0.05) was achieved
when the combined predictor had contributions comprised of 60% ACPP uptake and 40% remodeling ratio (e). Similarly, for the thrombin probe the maximum
AUC (0.92±0.05) was achieved when the combined predictor contributed by 80% ACPP uptake and 20% remodeling ratio (f).
doi:10.1371/journal.pone.0139833.g006
Table 2. Comparison of ROC results.
AUC Sensitivity Speciﬁcity
MMP-ACPP (FER) 0.79 80.0% 84.2%
Thrombin-ACPP (FER) 0.90 85.7% 83.2%
Remodeling ratio (RR) 0.69 58.5% 84.2%
Gd-DTPA (GdR) 0.51 NA NA
Combined: MMP-ACPP (FER): 60% RR: 40% 0.81 80.2% 81.0%
Combined:Thrombin-ACPP (FER): 80%RR: 20% 0.92 90.5% 83.2%
doi:10.1371/journal.pone.0139833.t002
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fractional flow reserve (FFR) can provide valuable information about the attainable blood flow
despite stenosis [36]. Positron emission tomography (PET) employing fluorine-18-labeled
2-deoxy-D-glucose (FDG), can reveal metabolic activity in advanced plaques [37]. Among
these technologies, targeted ACPPs have unique advantages. The uptake of ACPP can reflect
the level of the specific enzyme, which may directly participate in plaque destabilization. Its
special uptake mechanism can effectively amplify the signal locally. This type of imaging pro-
vides an activity-based visualization of plaques, which can be complementary to the morpho-
logical information typically obtained via imaging. In this study, both MMP and thrombin-
cleavable ACPPs appear to distinguish between disrupted and non-disrupted plaques. How-
ever, we have previously noted that only thrombin-cleavable and not MMP-cleavable ACPP
correlated with plaque severity in the ApoE-/- and LDLR-/- mice [7]. This difference likely
reflects variability between animal models, as our rodent models did not produce “disrupted
plaques”. There is some background uptake of the non-targeted control probe (PEG-ACPP) in
atherosclerotic regions (Fig 3c) which may be due to incomplete blocking of the CPP domain
by the inhibitory domain with the ACPP [7,28,38].
A crucial strategy of our study was to combine ACPP measurements and MRI derived pre-
dictors for plaque disruption, the pathophysiological end point of high-risk plaques. MRI
derived measures, outward remodeling and enhanced gadolinium-DTPA uptake, have been
linked to plaque destabilization in previous studies [14,39,40]. However, the calculation of RR
has limitations imposed by the necessity for mathematical modeling of the often complex
geometry of the vessel. Although the Gd-DTPA often shows uptake in vulnerable plaques, pas-
sive diffusion of the contrast agent into stable plaques often results in a high false positive rate.
Our data showed the MRI derived measures are inferior (AUC = 0.51–0.69) yet may comple-
ment ACPPs in detecting disrupted plaques. A larger AUC value is achieved by combining
contributions from both the ACPP and the remodeling ratio. However, due to passive diffusion
being a common occurrence shared by both Gd-DTPA and ACPPs, Gd-DTPA did not provide
additional information and thus cannot be used to improve the detecting power of the ACPPs.
The main limitation of using the Cy5 labeled ACPPs reported here is the necessity to
remove and expose the aorta for fluorescence imaging due to the relatively low penetration
depth of transmitted light. In addition, the probe contrast reaches its maximum at about the
6th hour, and the animal must then be sacrificed for imaging. This makes fluorescent imaging
with a 48-hour triggering period incompatible with probe injection prior to triggering rupture.
For future clinical applications, this limitation could be obviated by catheter-based imaging
[41] or possibly by imaging from outside the vessel wall during surgery. Both methods may
have potentials in pre-clinical settings, however, neither is currently used clinically, and such
methods would be quite invasive. It would be more desirable to use ACPPs to molecularly tar-
get MRI, as it allows for minimally invasive, in vivo applications, and therefore, a higher likeli-
hood for translational development. Additionally, MRI would permit the detection of probe
uptake in a pixel-by-pixel manner. This feature could clarify the potential ambiguity lying in
the current optic imaging setting for the source of signal increase: from elevated enzyme den-
sity, which indicates plaque destabilization, or merely from thickening of vessel wall, which is
observed more often in stable plaques. Furthermore, with remodeling ratio and ACPP uptake
that can be measured in the same MRI session, any systematic error caused by matching differ-
ent imaging modality will be eliminated. A challenge for molecularly targeted MRI probes to
overcome is the limitation of low sensitivity that has been achieved in studies with other probe
designs [42,43]. The design flexibility of the ACPPs has permitted delivery of detectable levels
of Gd in tumors for MRI imaging [44]. In another technical advance, we identified and
reported [38] an improved thrombin substrate, with the sequence Nle-TPRSFL, that increased
the kcat/Km for ACPP cleavage by thrombin by 55 fold in a mouse model. This increased
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enzyme sensitivity should lower the amount of probe needed, which in turn may lower the
potentially toxicity, and facilitate translation into the rabbit model for non-invasive MRI detec-
tion of destabilized plaques. Future development of gadolinium-loaded ACPPs for the MMPs
and thrombin would allow detection of enzymatic activity and vascular remodeling in a single
MRI examination and could significantly enhance in vivo diagnosis of vulnerable plaques at
high risk for disruption.
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